Turning Point Therapeutics Inc

NASDAQ:TPTX   3:59:51 PM EDT
62.67
-2.39 (-3.67%)
Products

Turning Point Therapeutics Granted FDA Orphan Drug Designation For Tpx-0022 In Gastric Cancer

Published: 06/17/2021 13:02 GMT
Turning Point Therapeutics Inc (TPTX) - Turning Point Therapeutics Granted FDA Orphan Drug Designation for Tpx-0022 in Gastric Cancer.